Randomized controlled trials of the renal protective effects of exerenone versus hydrochlorothiazide in hypertensive patients with CKD already on ACEI or ARB therapy.
Not Applicable
Recruiting
- Conditions
- chronic kidney disease
- Registration Number
- JPRN-UMIN000042560
- Lead Sponsor
- Yokohama City University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1)Pations with Secondary hypertension except renal parenchymal hypertension 2)Serum potassium 5mEq/L or higher 3)Nephrotic syndrome and active nephritis 4)Taking aldosterone antagonist
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method